Alirocumab Antibody
Alirocumab is a recombinant human monoclonal antibody targeting PCSK9, produced in CHO cells. It is widely used in cardiovascular research to study lipid metabolism, employing in vitro binding assays and in vivo models of hypercholesterolemia.
Product Specifications
Product Name Alternative
PCSK9, Alirocumab
Target
CXCR, Others, NOD-like Receptor (NLR), NF-κB, Nrf2
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation, Pharmacology & Drug Discovery, Signal Transduction
Concentration
24.7 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
146.2 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC403807-100 1x 100 µL
Nucleophosmin (Acute Myeloid Leukemia Marker) (rNPM1/1901), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401909-100 1x 100 µL
AIF1 / Iba1 (Microglia Marker) (AIF1/1909), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details